EUVIMEDEUVIMED entdecken
Crossref

Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity

Yi-Ying Kuo, Hao-Yeh Tsai, Yu-Min Kuo, Shun-Fen Tzeng, Po-See Chen, Po-Hung Hsu, Ya-Tin Lin, Pei-Chun Chen

Life Sciences · 2023

DOI: 10.1016/j.lfs.2023.121900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2023. Verfasst von Yi-Ying Kuo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan; Institue of Basic Medical Sciences…. Hauptthemen laut MEDLINE: Adipose Tissue, Brown, Depression, Fibroblast Growth Factors, Glyburide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Taiwan Ministry of Science and Technology, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Epidemiological evidence suggests that comorbidity of obesity and depression is extremely common and continues to grow in prevalence. However, the mechanisms connecting these two conditions are unknown. In this study, we explored how treatment with KATP channel blocker glibenclamide (GB) or the well-known metabolic regulator FGF21 impact male mice with high-fat diet (HFD)-induced obesity and depressive-like behaviors. MATERIALS AND METHODS: Mice were fed with HFD for 12 weeks and then treated with recombinant FGF21 protein by infusion for 2 weeks, followed by intraperitoneal injection of 3 mg/kg recombinant FGF21 once per day for 4 days. Measurements were made of catecholamine levels, energy expenditure, biochemical endpoints and behavior tests, including sucrose preference and forced swim tests were. Alternatively, animals were infused with GB into brown adipose tissue (BAT). The WT-1 brown adipocyte cell line was used for molecular studies. KEY FINDINGS: Compared to HFD controls, HFD + FGF21 mice exhibited less severe metabolic disorder symptoms, improved depressive-like behaviors, and more extensive mesolimbic dopamine projections. FGF21 treatment also rescued HFD-induced dysregulation of FGF21 receptors (FGFR1 and co-receptor β-klotho) in the ventral tegmental area (VTA), and it altered dopaminergic neuron activity and morphology in HFD-fed mice. Importantly, we also found that FGF21 mRNA level and FGF21 release were increased in BAT after administration of GB, and GB treatment to BAT reversed HFD-induced dysregulation of FGF21 receptors in the VTA. SIGNIFICANCE: GB administration to BAT stimulates FGF21 production in BAT, corrects HFD-induced dysregulation of FGF21 receptor dimers in VTA dopaminergic neurons, and attenuates depression-like symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose Tissue, BrownDepressionFibroblast Growth FactorsGlyburideHypoglycemic AgentsObesityAnimalsMaleMiceDiet, High-FatMetabolic DiseasesMice, Inbred C57BLNeuronsReceptors, Fibroblast Growth FactorVentral Tegmental AreaRecombinant Proteins

Stichwörter der Autor:innen

Depressive-like behaviorDopaminergic transmissionFGF21GlibenclamideMetabolic disordersObesity

Substanzen

fibroblast growth factor 21Fibroblast Growth FactorsGlyburideHypoglycemic AgentsReceptors, Fibroblast Growth FactorRecombinant Proteins

Autor:innen und Institutionen

  • Department of Physiology, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan; Institue of Basic Medical Sciences, College of Medicine, College of Bioscience and Biotechnology, Nation…
  • Department of Physiology, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
  • Department of Cell Biology and Anatomy, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
  • Department of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
  • Department of Psychiatry, National Cheng Kung University Hospital, Taiwan.
  • Department of Medical Research and Development, Chang Gung Memorial Hospital, Linkou, Taiwan.

Förderung

  • Taiwan Ministry of Science and Technology
  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Kuo, Y. Y., Tsai, H. Y., Kuo, Y. M., Tzeng, S. F., Chen, P. S., Hsu, P. H., Lin, Y. T., & Chen, P. C. (2023). Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity. Life Sciences. https://doi.org/10.1016/j.lfs.2023.121900

Vancouver

Kuo YY, Tsai HY, Kuo YM, Tzeng SF, Chen PS, Hsu PH, et al. Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity. Life Sciences. 2023. doi:10.1016/j.lfs.2023.121900

BibTeX
@article{Kuo2023,
  author = {Kuo, Yi-Ying and Tsai, Hao-Yeh and Kuo, Yu-Min and Tzeng, Shun-Fen and Chen, Po-See and Hsu, Po-Hung and Lin, Ya-Tin and Chen, Pei-Chun},
  title = {Glibenclamide promotes FGF21 secretion in interscapular BAT and attenuates depression-like behaviors in male mice with HFD-induced obesity},
  journal = {Life Sciences},
  year = {2023},
  doi = {10.1016/j.lfs.2023.121900}
}
Kostenlos starten →